National Research Center for Applied Cybersecurity ATHENE
Actualités de San Diego
- plus
- 8
Artworld Disruption: Swiss Artist Presents Exhibition Simultaneously in 30 Museums Worldwide
plus The Human Kind Institute partners with Fashion 4 Development to Convene Heads of UN Delegations, First Ladies, Ambassadors, and VIPs for United Nations General Assembly Week
London (ots/PRNewswire) - In the Presence of World Leaders, First Ladies, and Diplomats, the 3rd Sustainable Goals Banquet and 11th Annual First Ladies Luncheon Honoured Agents of Change and Further HKI's and F4D's Commitment to the UN Sustainable Goals. The Human Kind Institute and Fashion 4 Development (F4D) ...
plusAurisco Expands Oligonucleotide Capacity and Launches New Website
SETÚBAL, Portugal (ots/PRNewswire) - The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs. The new website shows how R&D and Innovation is the driving force of its sustainable growth, featuring its technologies, capabilities, services and products, including Oligonucleotides, peptides and small molecules ...
plusAurisco Expands Oligonucleotide Capacity and Launches New Website
SETÚBAL, Portugal (ots/PRNewswire) - The New State-of-Art OligoPilot 2000TM solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs. The new website shows how R&D and Innovation is the driving force of its sustainable growth, featuring its technologies, capabilities, services and products, including Oligonucleotides, peptides and small molecules ...
plusFirmenich Appoints Dr. Sarah Reisinger as Chief Research Officer
Geneva (ots/PRNewswire) - Firmenich, the world's largest privately owned fragrance and taste company, appoints Sarah Reisinger as Chief Research Officer, effective July 1, 2021. She will report to the Group CEO, Gilbert Ghostine, as a member of his executive team after most recently serving as Senior Vice President of Research Operations. Dr. Reisinger will succeed ...
plusBram Goorden joins SOPHiA GENETICS as Chief Commercial Officer and Head of North America
Boston and Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Bram Goorden joined its Executive team, holding the dual role of Chief Commercial Officer and Head of North America. Goorden comes to SOPHiA from Foundation Medicine Inc. (Cambridge, MA) where he held the role of VP of International Business and ...
plusFirstlight Media and ThinkAnalytics Partner to Turbocharge OTT Personalization
Toronto and London (ots/PRNewswire) - Combined Solution will be Previewed at IBC Showcase Event Firstlight Media and ThinkAnalytics are partnering to enable OTT and pay-TV providers to deploy powerful new cloud-native personalization capabilities that drive long-term subscriber value. The two companies will leverage Firstlight Media's content management system (CMS) ...
plusNew GSK Multi-country Survey Reveals Need for Improved Awareness Around Long-term Impact and Appropriate use of Corticosteroids in SLE Management
San Diego and London (ots/PRNewswire) - Findings from a new multi-country GSK survey, released today to coincide with the 2017 American College of Rheumatology/Association for Rheumatology Health Professionals Annual Meeting (ACR/AHRP), reveal that patients with systemic lupus erythematosus (SLE) often self-manage ...
plusTresiba® Demonstrated No Increased Risk Of Major Cardiovascular Events and Significant Reduction in Rates of Severe Hypoglycaemia Compared to Insulin Glargine U100 in the DEVOTE Trial
San Diego (ots/PRNewswire) - Symposium: 3-CT-SY22 Novo Nordisk today announced the primary results from DEVOTE - the first randomised, double-blind, treat-to-target, event-driven trial comparing two basal insulins, Tresiba® (insulin degludec injection 100 U/mL) and insulin glargine U100, in adults with type 2 ...
plusHelsinn Group and MEI Pharma Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
Lugano, Switzerland and San Diego (ots/PRNewswire) - Phase 2 study results presented at American Society of Hematology Annual Meeting on Saturday, December 3, 2016 Global Phase 3 study site recruitment is ongoing Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, ...
plusHelsinn Group and MEI Pharma Announce Long-Term Survival and Response Data from Phase II Clinical Study of Pracinostat in Acute Myeloid Leukemia Accepted for Oral Presentation at Upcoming American Society of Hematology Annual Meeting
Lugano, Switzerland and San Diego (ots/PRNewswire) - Data to be presented on December 3, 2016; Abstract now available online Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel ...
plusShire plc and Lumena Pharmaceuticals
Shire Adds to Rare Disease Portfolio with Acquisition of Lumena Pharmaceuticals, Bringing Late Stage Compounds for Rare GI/Hepatic Conditions
Dublin And San Diego (ots/PRNewswire) - - Acquisition of Lumena Pharmaceuticals, a biopharmaceutical company with late stage rare disease pipeline assets - Adds to Shire's rare diseases portfolio and leverages this expertise, and is a perfect combination with Shire's already strong Gastrointestinal (GI) presence - ...
plusAtego Launches Atego Asset Library
San Diego And Cheltenham, England (ots/PRNewswire) - Atego provides a highly scalable, web based, system and software engineering asset repository, enabling publication, discovery and reuse. Atego Asset Library - Communication Platform Atego(TM), the leading independent supplier of collaborative development tools for engineering complex, mission- and safety-critical systems and software, has launched Atego Asset Library, a ground breaking repository, enabling large-scale ...
plusAtego Releases Aonix ObjectAda 8.5 for Windows
San Diego And Cheltenham, England (ots/PRNewswire) - Ada development and compilation system enhanced for Microsoft Windows 7 Atego(TM), the leading independent supplier of industrial-grade, collaborative development tools for engineering complex, mission- and safety-critical architectures, systems, software and hardware, has launched Aonix ObjectAda(R) 8.5 for Windows with new support for Microsoft Windows(R) 7 systems. ...
plusAtego Launches Aonix Perc Ultra SMP 6.1
San Diego, And Cheltenham, England (ots/PRNewswire) - Next-generation embedded Virtual Machine and compilation technology for Symmetrical Multi-Processor systems Atego(TM), the leading independent supplier of industrial-grade, collaborative development tools for engineering complex, mission- and safety-critical architectures, systems, software and hardware, has launched Aonix Perc Ultra(R) SMP 6.1, its next-generation ...
plusAtego Acquires IBM Rational Apex Ada Developer Product Family
San Diego, California And Cheltenham, England (ots/PRNewswire) - Adds Ada IDE for mixed Ada/C/C++ application and embedded software development. Atego, the leading independent supplier of industrial-grade, collaborative development tools for engineering complex, mission- and safety-critical architectures, systems, software and hardware, has entered into an agreement with International Business Machines Corporation to ...
plusLaunch of Artisan Studio 7.4 Delivers All New Systems Simulation, Plus Additional Modeling Features and Benefits
San Diego And Cheltenham, England (ots/PRNewswire) - This release introduces Artisan Studio SySim for system level simulation; plus improvements to sandboxing, differencing, state machines and IDL3/IDL3+ generation/reversing Atego(TM), the world leading software tools and professional services supplier for complex, ...
plusAtego Launches Atego Process Director for DO-178
San Diego, California And Cheltenham, England (ots/PRNewswire) - DO-178 process templates jump-start certified airborne software projects, enhancing process definition, deployment, management and refinement. Atego Process Director's DO-178 Process Library Atego(TM), the world leading software tools and professional services supplier for complex, mission- and safety-critical systems and software engineering has launched ...
plusPieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin® Program at ASH Annual Meeting
San Diego, CA, USA (ots) - Breadth of Pharmacokinetic Data Points to Tunable Half-life for Platform Pieris AG presented novel preclinical in vitro and in vivo data for its PRS-080 Anticalin hepcidin antagonist in an oral presentation at the American Society of Hematology Annual Meeting, the company announced today. ...
plus